FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Blumenkranz

Research Profile

Anatomy

Physiology

Visual Acuity

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Living Beings

Rabbits

Devices

Drug Delivery Systems

Co-author Network

Publications

TOP 3
Ruwan A Silva; Audina M Berrocal; Mark S Blumenkranz; Darius M Moshfeghi; Steven R Sanislo; Janet L Davis
Herpes simplex virus type 2 mediated acute retinal necrosis in a pediatric population: case series and review.
Hiroyuki Nomoto; Yannis Paulus; Mark S Blumenkranz; Roopa Dalal; Daniel Lavinsky; Loh-Shan Leung; Daniel Palanker
Effect of intravitreal triamcinolone acetonide on healing of retinal photocoagulation lesions.
Daniel Palanker; Mark S Blumenkranz
Panretinal photocoagulation for proliferative diabetic retinopathy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Blumenkranz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ruwan A Silva; Audina M Berrocal; Mark S Blumenkranz; Darius M Moshfeghi; Steven R Sanislo; Janet L Davis
Herpes simplex virus type 2 mediated acute retinal necrosis in a pediatric population: case series and review.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2013;251(2):559-66.
2013: Hiroyuki Nomoto; Yannis Paulus; Mark S Blumenkranz; Roopa Dalal; Daniel Lavinsky; Loh-Shan Leung; Daniel Palanker
Effect of intravitreal triamcinolone acetonide on healing of retinal photocoagulation lesions.
Retina (Philadelphia, Pa.) 2013;33(1):63-70.
2012: Daniel Palanker; Mark S Blumenkranz
Panretinal photocoagulation for proliferative diabetic retinopathy.
American journal of ophthalmology 2012;153(4):780-1; author reply 781-2.
2012: Harry W Flynn; Mark S Blumenkranz
Tennis partners.
Retina (Philadelphia, Pa.) 2012;32 Suppl 1():S12-4.
2012: Boris V Stanzel; Susanne Binder; Mark S Blumenkranz; Michael F Marmor
Longterm cultures of the aged human RPE do not maintain epithelial morphology and high transepithelial resistance.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2012;250(2):313-5.
2012: Loh-Shan B Leung; Mark S Blumenkranz; Harry W Flynn; Ruwan A Silva; Steven R Sanislo
Macular infarction following intravitreal bevacizumab for treatment of central retinal vein occlusion.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2012;43():e73-9.
2011: Julia A Haller; Jeffrey Heier; Jenny Jiao; Xiao-Yan Li; Anat Loewenstein; Scott M Whitcup; Young Hee Yoon; Francesco Bandello; Rubens Belfort; Mark S Blumenkranz; Mark Gillies; Joanne Li
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
Ophthalmology 2011;118(12):2453-60.
2011: Neil J Friedman; George Marcellino; Daniel Palanker; Georg Schuele; Barry S Seibel; Jonathan H Talamo; Dan Andersen; Juan Batlle; Mark S Blumenkranz; Rafael Feliz; William W Culbertson
Femtosecond laser capsulotomy.
Journal of cataract and refractive surgery 2011;37(7):1189-98.
2011: Annie Chan; Loh-Shan Leung; Mark S Blumenkranz
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion.
Clinical ophthalmology (Auckland, N.Z.) 2011;5():1043-9.
2010: Daniel Palanker; Mark S Blumenkranz; Dan Andersen; Michael Wiltberger; George Marcellino; Phillip Gooding; David Angeley; Georg Schuele; Bruce Woodley; Michael Simoneau; Neil J Friedman; Barry Seibel; Juan Batlle; Rafael Feliz; Jonathan Talamo; William W Culbertson
Femtosecond laser-assisted cataract surgery with integrated optical coherence tomography.
Science translational medicine 2010;2(58):58ra85.
2010: Mark S Blumenkranz; Julia A Haller; Baruch D Kuppermann; George A Williams; Michael Ip; Matthew Davis; David V Weinberg; Connie Chou; Scott M Whitcup
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema.
Retina (Philadelphia, Pa.) 2010;30(7):1090-4.
2010: Julia A Haller; Francesco Bandello; Rubens Belfort; Mark S Blumenkranz; Mark Gillies; Jeffrey Heier; Anat Loewenstein; Young-Hee Yoon; Marie-Louise Jacques; Jenny Jiao; Xiao-Yan Li; Scott M Whitcup
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Ophthalmology 2010;117(6):1134-1146.e3.
2010: Baruch D Kuppermann; Connie Chou; David V Weinberg; Scott M Whitcup; Julia A Haller; Mark S Blumenkranz
Intravitreous dexamethasone effects on different patterns of diabetic macular edema.
Archives of ophthalmology 2010;128(5):642-3.
2010: Julia A Haller; Baruch D Kuppermann; Mark S Blumenkranz; George A Williams; David V Weinberg; Connie Chou; Scott M Whitcup
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.
Archives of ophthalmology 2010;128(3):289-96.
2010: Adam de la Zerda; Yannis Paulus; Robert Teed; Sunil Bodapati; Yosh Dollberg; Butrus T Khuri-Yakub; Mark S Blumenkranz; Darius M Moshfeghi; Sanjiv Sam Gambhir
Photoacoustic ocular imaging.
Optics letters 2010;35(3):270-2.
2009: Annie Chan; Mark S Blumenkranz; Kathy H C Wu; Gloria Wang; Nilufer Berker; Layla M Parast; Steven R Sanislo
Photodynamic therapy with and without adjunctive intravitreal triamcinolone acetonide: a retrospective comparative study.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2009;40(6):561-9.
2009: George A Williams; Julia A Haller; Baruch D Kuppermann; Mark S Blumenkranz; David V Weinberg; Connie Chou; Scott M Whitcup
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome.
American journal of ophthalmology 2009;147(6):1048-54, 1054.e1-2.
2008: Yannis Paulus; Atul Jain; Ray F Gariano; Boris V Stanzel; Michael Marmor; Mark S Blumenkranz; Daniel Palanker
Healing of retinal photocoagulation lesions.
Investigative ophthalmology & visual science 2008;49(12):5540-5.
2008: Lisa J Wong; Rajen U Desai; Atul Jain; David Feliciano; Darius M Moshfeghi; Steven R Sanislo; Mark S Blumenkranz
Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.
Retina (Philadelphia, Pa.) 2008;28(8):1151-8.
2008: John J de Caro; Christopher N Ta; Hoai-Ky V Ho; Lorella Cabael; Nan Hu; Steven R Sanislo; Mark S Blumenkranz; Darius M Moshfeghi; Robert Jack; Herminia Miño de Kaspar
Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections.
Retina (Philadelphia, Pa.) 2008;28(6):877-83.
2008: Atul Jain; Mark S Blumenkranz; Yannis Paulus; Michael W Wiltberger; Dan E Andersen; Philip Huie; Daniel Palanker
Effect of pulse duration on size and character of the lesion in retinal photocoagulation.
Archives of ophthalmology 2008;126(1):78-85.
2007: Atul Jain; Peter R Egbert; Timothy J McCulley; Mark S Blumenkranz; Darius M Moshfeghi
Endogenous Scedosporium apiospermum endophthalmitis.
Archives of ophthalmology 2007;125(9):1286-9.
2007: Shawn M Ronan; Pradeepa Yoganathan; Fred Y Chien; Iñigo A Corcóstegui; Mark S Blumenkranz; Vincent Deramo; Susan G Elner; David A Fastenberg; Mark W Johnson; Mauricio López; Carlos Mateo; Darius M Moshfeghi; Rafael Navarro; Brett J Rosenblatt; Steven R Sanislo; Stephen J Saxe; David N Zacks
Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Retina (Philadelphia, Pa.) 2007;27(5):535-40.
2007: Darius M Moshfeghi; Mark S Blumenkranz
Role of genetic factors and inflammation in age-related macular degeneration.
Retina (Philadelphia, Pa.) 2007;27(3):269-75.
2007: Baruch D Kuppermann; Mark S Blumenkranz; Julia A Haller; George A Williams; David V Weinberg; Connie Chou; Scott M Whitcup
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.
Archives of ophthalmology 2007;125(3):309-17.
2007: M J Koss; M Eder; Mark S Blumenkranz; Volker Klauss; Christopher N Ta; Herminia Miño de Kaspar
[The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2007;104(1):21-7.
2006: Ruth J Lin; Mark S Blumenkranz; Jonathan Binkley; Kathy Wu; Douglas Vollrath
A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.
American journal of ophthalmology 2006;142(5):839-48.
2006: Mark S Blumenkranz; Dimitri Yellachich; Dan E Andersen; Michael W Wiltberger; David Mordaunt; George R Marcellino; Daniel Palanker
Semiautomated patterned scanning laser for retinal photocoagulation.
Retina (Philadelphia, Pa.) 2006;26(3):370-6.
2005: Philip J Rosenfeld; Steven D Schwartz; Mark S Blumenkranz; Joan W Miller; Julia A Haller; James D Reimann; William L Greene; Naveed Shams
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.
Ophthalmology 2005;112(6):1048-53.
2005: Herminia Miño de Kaspar; Michael J Koss; Lingmin He; Mark S Blumenkranz; Christopher N Ta
Antibiotic susceptibility of preoperative normal conjunctival bacteria.
American journal of ophthalmology 2005;139(4):730-3.
2005: Mark S Blumenkranz
New therapy for central retinal vein occlusion: are intravitreal steroids a possible answer?
Archives of ophthalmology 2005;123(2):259-61.
2005: Herminia Miño de Kaspar; Robert Chang; Kuldev Singh; Peter R Egbert; Mark S Blumenkranz; Christopher N Ta
Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery.
Archives of ophthalmology 2005;123(2):161-5.
2004: Theodore Leng; Peggy Wu; Neville Z Mehenti; Stacey F Bent; Michael F Marmor; Mark S Blumenkranz; Harvey A Fishman
Directed retinal nerve cell growth for use in a retinal prosthesis interface.
Investigative ophthalmology & visual science 2004;45(11):4132-7.
2004: Daniel Palanker; Philip Huie; Alexander Vankov; Robert B Aramant; Magdalene Seiler; Harvey A Fishman; Michael Marmor; Mark S Blumenkranz
Migration of retinal cells through a perforated membrane: implications for a high-resolution prosthesis.
Investigative ophthalmology & visual science 2004;45(9):3266-70.
2004: Mark C Peterman; Jaan Noolandi; Mark S Blumenkranz; Harvey A Fishman
Localized chemical release from an artificial synapse chip.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(27):9951-4.
2004: Herminia Miño de Kaspar; Robert Chang; Erin M. Shriver; Kuldev Singh; Peter R Egbert; Mark S Blumenkranz; Christopher N Ta
Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in cataract surgery: a prospective randomized study.
Ophthalmology 2004;111(7):1352-5.
2004: Theodore Leng; Jason M Miller; Kalayaan V Bilbao; Daniel Palanker; Philip Huie; Mark S Blumenkranz
The chick chorioallantoic membrane as a model tissue for surgical retinal research and simulation.
Retina (Philadelphia, Pa.) 2004;24(3):427-34.
2004: Christina J Lee; Mark S Blumenkranz; Harvey A Fishman; Stacey F Bent
Controlling cell adhesion on human tissue by soft lithography.
Langmuir : the ACS journal of surfaces and colloids 2004;20(10):4155-61.
2004: Christopher N Ta; Peter R Egbert; Kuldev Singh; Mark S Blumenkranz; Herminia Miño de Kaspar
The challenge of determining aqueous contamination rate in anterior segment intraocular surgery.
American journal of ophthalmology 2004;137(4):662-7.
2004: Mark C Peterman; Jaan Noolandi; Mark S Blumenkranz; Harvey A Fishman
Fluid flow past an aperture in a microfluidic channel.
Analytical chemistry 2004;76(7):1850-6.
2003: J Donald M Gass; Raymond J Sever; W Sanderson Grizzard; John Clarkson; Mark S Blumenkranz; Chiel A Wind; Richard Shugarman
Multifocal pigment epithelial detachments by reticulum cell sarcoma: a characteristic funduscopic picture. 1984.
Retina (Philadelphia, Pa.) 2003;23(6 Suppl):135-43.
2003: Mark C Peterman; Neville Z Mehenti; Kalayaan V Bilbao; Christina J Lee; Theodore Leng; Jaan Noolandi; Stacey F Bent; Mark S Blumenkranz; Harvey A Fishman
The Artificial Synapse Chip: a flexible retinal interface based on directed retinal cell growth and neurotransmitter stimulation.
Artificial organs 2003;27(11):975-85.
2003: Christopher N Ta; Robert Chang; Kuldev Singh; Peter R Egbert; Erin M. Shriver; Mark S Blumenkranz; Herminia Miño de Kaspar
Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery.
Ophthalmology 2003;110(10):1946-51.
2003: Herminia Miño de Kaspar; Erin M. Shriver; Eddy V Nguyen; Peter R Egbert; Kuldev Singh; Mark S Blumenkranz; Christopher N Ta
Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2003;241(9):730-3.
2003: Mark C Peterman; David M Bloom; Christina Lee; Stacey F Bent; Michael F Marmor; Mark S Blumenkranz; Harvey A Fishman
Localized neurotransmitter release for use in a prototype retinal interface.
Investigative ophthalmology & visual science 2003;44(7):3144-9.
2003: Saad Shaikh; Naazli Shaikh; Sung H Chun; Joshua M Spin; Mark S Blumenkranz; Michael F Marmor
Retinal evaluation of patients on chronic amiodarone therapy.
Retina (Philadelphia, Pa.) 2003;23(3):354-9.
2003: Jason M Miller; Daniel Palanker; Alexander Vankov; Michael F Marmor; Mark S Blumenkranz
Precision and safety of the pulsed electron avalanche knife in vitreoretinal surgery.
Archives of ophthalmology 2003;121(6):871-7.
2003: Kevin J Blinder; Mark S Blumenkranz; Neil M Bressler; Susan B Bressler; Guy Donato; Hilel Lewis; Jennifer I Lim; Ugo Menchini; Joan W Miller; Jordi Mones; Michael J Potter; Constantin J Pournaras; Al Reaves; Philip J Rosenfeld; Andrew P Schachat; Ursula Schmidt-Erfurth; Michel Sickenberg; Lawrence J Singerman; Jason S Slakter; H Andrew Strong; Gianni Virgili; George A Williams
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
Ophthalmology 2003;110(4):667-73.
2003: Darius M Moshfeghi; Peter K Kaiser; Hans E Grossniklaus; Paul Sternberg; Jonathan E Sears; Mark W Johnson; Norman B Ratliff; Andre Branco; Mark S Blumenkranz; Hilel Lewis
Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.
American journal of ophthalmology 2003;135(3):343-50.
2002: Christina J Lee; Philip Huie; Theodore Leng; Mark C Peterman; Michael F Marmor; Mark S Blumenkranz; Stacey F Bent; Harvey A Fishman
Microcontact printing on human tissue for retinal cell transplantation.
Archives of ophthalmology 2002;120(12):1714-8.
2002: Neil M Bressler; Jennifer Arnold; Mustapha Benchaboune; Mark S Blumenkranz; Gary Edd Fish; Evangelos S Gragoudas; Hilel Lewis; Ursula Schmidt-Erfurth; Jason S Slakter; Susan B Bressler; Kelly Manos; Yong Hao; Laurie Hayes; John M Koester; Al Reaves; H Andrew Strong
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
Archives of ophthalmology 2002;120(11):1443-54.
2002: Christopher N Ta; Peter R Egbert; Kuldev Singh; Erin M. Shriver; Mark S Blumenkranz; Herminia Miño de Kaspar
Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery.
Ophthalmology 2002;109(11):2036-40; discussion 2040-1.
2002: HarHiu D Lam; Mark S Blumenkranz
Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection, and photocoagulation.
American journal of ophthalmology 2002;134(4):609-11.
2002: Mark S Blumenkranz; Neil M Bressler; Susan B Bressler; Guy Donati; Gary Edd Fish; Laurie A Haynes; Hilel Lewis; Joan W Miller; Jordi M Monés; Michael J Potter; Constantin J Pournaras; Al Reaves; Philip J Rosenfeld; Andrew P Schachat; Ursula Schmidt-Erfurth; Michel Sickenburg; Lawrence J Singerman; Jason S Slakter; Andrew Strong; Stéphane Vannier
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.
Archives of ophthalmology 2002;120(10):1307-14.
2002: Daniel A Fletcher; Daniel Palanker; Philip Huie; Jason Miller; Michael F Marmor; Mark S Blumenkranz
Intravascular drug delivery with a pulsed liquid microjet.
Archives of ophthalmology 2002;120(9):1206-8.
2002: Kathryn W Woodburn; Christopher J Engelman; Mark S Blumenkranz
Photodynamic therapy for choroidal neovascularization: a review.
Retina (Philadelphia, Pa.) 2002;22(4):391-405; quiz 527-8.
2002: Danny Y Lin; Mark S Blumenkranz; Rosemary J Brothers; David M Grosvenor
The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography.
American journal of ophthalmology 2002;134(2):204-13.
2002: Daniel Palanker; Michael F Marmor; Andre Branco; Philip Huie; Jason M Miller; Steven R Sanislo; Alexander Vankov; Mark S Blumenkranz
Effects of the pulsed electron avalanche knife on retinal tissue.
Archives of ophthalmology 2002;120(5):636-40.
2001: Daniel Palanker; Jason M Miller; Michael F Marmor; Steven R Sanislo; Philip Huie; Mark S Blumenkranz
Pulsed electron avalanche knife (PEAK) for intraocular surgery.
Investigative ophthalmology & visual science 2001;42(11):2673-8.
2001: Mark S Blumenkranz; E Ohana; Saad Shaikh; S Chang; G Coll; Lawrence S Morse; S De Bustros
Adjuvant methods in macular hole surgery: intraoperative plasma-thrombin mixture and postoperative fluid-gas exchange.
Ophthalmic surgery and lasers 2001;32(3):198-207.
2001: Saad Shaikh; Mark S Blumenkranz
Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy.
Retina (Philadelphia, Pa.) 2001;21(2):176-8.
2001: Saad Shaikh; Mark S Blumenkranz
Fluorescein angiographic findings in ocular siderosis.
American journal of ophthalmology 2001;131(1):136-8.
2000: Mark S Blumenkranz; Kathryn W Woodburn; F Qing; S Verdooner; David Kessel; R Miller
Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy.
American journal of ophthalmology 2000;129(3):353-62.
2000: Saad Shaikh; N Shaikh; Mark S Blumenkranz
Fluorescein angiographic changes in acute toxic retinopathy associated with polypharmacy.
Retina (Philadelphia, Pa.) 2000;20(6):685-8.
1998: M Humayun; Hilel Lewis; Harry W Flynn; P Sternberg; Mark S Blumenkranz
Management of submacular hemorrhage associated with retinal arterial macroaneurysms.
American journal of ophthalmology 1998;126(3):358-61.
1998: E Ohana; Mark S Blumenkranz
Treatment of reopened macular hole after vitrectomy by laser and outpatient fluid-gas exchange.
Ophthalmology 1998;105(8):1398-403.
1997: Lawrence S Morse; C B Chapman; Dean Eliott; J D Benner; Mark S Blumenkranz; B W McCuen
Subretinal hemorrhages in proliferative diabetic retinopathy.
Retina (Philadelphia, Pa.) 1997;17(2):87-93.